BhumikaJayantibhaiPatelMD

PubMed

• 27 citations
  Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome.
  Courtney D DiNardo, Sangeetha Venugopal, Curtis Lachowiez, Koichi Takahashi, Sanam Loghavi
  Blood Advances. 2023-06-13
• 7 citations
  Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes.
  Sanghee Hong, Lisa Rybicki, Carmelo Gurnari, Simona Pagliuca, Aiwen Zhang
  Bone Marrow Transplantation. 2022-10-01
• 31 citations
  Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria.
  Carmelo Gurnari, Simona Pagliuca, Pedro Henrique Prata, Jacques-Emmanuel Galimard, Luiz Fernando B Catto
  Journal of Clinical Oncology. 2023-01-01

Abstracts/Posters

• RORA Is a Potential Prognostic Biomarker and Therapeutic Target for Patients with Acute Myeloid Leukemia
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Extended Experience with a Very Low Dose, Metronomic, Subcutaneous Decitabine Regimen Intended to Deplete DNMT1 without Cytotoxicity
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Are Racial Disparities in Acute Myeloid Leukemia (AML) Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• ANKRD26 Coding Variants Presenting with Giant Platelets and a Predisposition to Myeloid Neoplasia
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Effects of the Therapeutic Armamentarium on Survival and Time to Next Treatment in CMML Subtypes: An International Analysis of 950 Cases Coordinated By the AGMT Study ...
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• FA Gene Carrier Status Predisposes to Myeloid Neoplasms and Bone Marrow Failure in AdultsClinically Relevant Abstract
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Personalized Prediction Model to Risk Stratify Patients with Acute Myeloid Leukemia (AML) Using Artificial Intelligence
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Mutational Type and Configuration of an Individual Gene May Differentially Impact the Clinical and Phenotypic Features
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Determinants of Fitness for Intensive Therapy Among Acute Myeloid Leukemia (AML) Patients
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Identifying Factors That Predict for Unplanned Readmissions for Acute Myeloid Leukemia Patients Receiving Consolidation Cytarabine Based Therapies
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Eltrombopag Creates a Transient Chemical Phenocopy of TET2 Loss of Function That Contributes to Hematopoietic Precursor ExpansionClinically Relevant Abstract
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Large Granular Lymphocytic Leukemia Coexists with Clonal Hematopoiesis of Indeterminate PotentialClinically Relevant Abstract
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all